The use of triptans as an effective form of migraine treatment – review by Agata Borkowska, Anna Kiełb, Anna Mich, Anna Kaźmierczak, Patrycja Sornek, Wiktoria Izdebska, Igor Pawlak, Radosław Ciesielski, Jakub Stanek, Klaudia Perkowska

Subjects: Get full text

Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) by Luigi Francesco Iannone, Gloria Vaghi, Gabriele Sebastianelli, Francesco Casillo, Antonio Russo, Marcello Silvestro, Francesca Pistoia, Giorgio Dalla Volta, Matteo Cortinovis, Alberto Chiarugi, Danilo Antonio Montisano, Maria Pia Prudenzano, Sabina Cevoli, Edoardo Mampreso, Gianluca Avino, Marina Romozzi, Mariarosaria Valente, Carla Fasano, Stefania Battistini, Antonio Granato, Elisa Maria Piella, Innocenzo Rainero, Raffaele Ornello, Roberto De Icco, On behalf of the Italian Headache Registry (RICe) Study Group

Subjects: Get full text

Migraine headaches in a nutshell by Natalie Schellack, O Mogole, N Magongwa, F Makola

Subjects: Get full text

Seasonal Variations in Triptan Prescription in Japan: A Nationwide Time‐Series Analysis by Muneto Tatsumoto, Koichi Hirata, Takeo Nakayama, Kentaro Yamato, Hiromi Sano, Lyo Inuyama

Subjects: Get full text

NSAIDs and Triptans – a (not) New Treatment Option for Migraine by B. Kakta, Rasa Mameniškienė

Subjects: Get full text

Differences in pharmacological migraine treatment across different levels of clinical headache care – a cross-sectional study by Mira Pauline Fitzek, Lucas Hendrik Overeem, Marlene Ulrich, Ja Bin Hong, Carolin Luisa Hoehne, Kristin Sophie Lange, Yones Salim, Uwe Reuter, Bianca Raffaelli

Subjects: Get full text

Evaluating Triptan Safety in Pediatric Migraine Management: A Comprehensive Pharmacovigilance Analysis by Chen J, Huang S, Chen Y, Luo C, Li Y

Subjects: “…Triptans…”
Get full text

Efficacy and safety of Russian tableted rizatriptan 10 mg in the treatment of migraine attacks in clinical practice by E. G. Filatova, N. V. Latysheva, N. B. Kadymova, A. V. Berdnikova

Subjects: Get full text

Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug by Krymchantowski Abouch V., Barbosa Jackeline Soraya

Subjects: Get full text

The triptan formulations: a critical evaluation Formulações dos triptanos: avaliacão crítica by Marcelo E. Bigal, Carlos A. Bordini, Ana L. Antoniazzi, José G. Speciali

Subjects: Get full text

The impact of headache specialist density and the introduction of gepants and lasmitidan on prescriptions for acute migraine treatments: a regression and interrupted time series an... by Leon S. Moskatel, Rebecca Y. Linfield, Niushen Zhang

Subjects: Get full text

The Burden of Menstrual Migraine: Advances in diagnosis, treatment, and understanding of pathogenesis by Paulina Głogowska, Daria Furtak, Dawid Tulej, Alicja Dziedzic, Wiktor Grela, Jagoda Niewiadomska, Natalia Marko, Natalia Gniaź, Dominika Marciniuk, Aleksandra Górska

Subjects: Get full text

Gepants in Primary Care: A Targeted Approach to Acute and Preventive Treatment of Migraine by Maureen A. Moriarty, Carol A. Barch

Subjects: Get full text

Migraine in the triptan era: progresses achieved, lessons learned and future developments Migrânea na era dos triptanos: progressos alcançados, lições aprendidas e desenvolvimentos... by Marcelo E. Bigal, Abouch V. Krymchantowski, Tony Ho

Subjects: Get full text

Prevalence, characteristics and management of migraine patients with triptan failure in primary care: the EMR France-Mig study by M. Lanteri-Minet, C. Casarotto, O. Bretin, C. Collin, M. Gugenheim, V. Raclot, A. Cases, P. A. Squara, W. Aissani, A. Saighi, H. Lefebvre

Subjects: Get full text

Efficacy of lasmiditan, rimegepant and ubrogepant for acute treatment of migraine in triptan insufficient responders: systematic review and network meta-analysis by Wattakorn Laohapiboolrattana, Priabprat Jansem, Prakit Anukoolwittaya, Duangnapa Roongpiboonsopit, Akarin Hiransuthikul, Thanakit Pongpitakmetha, Sekh Thanprasertsuk, Wanakorn Rattanawong

Subjects: “…Triptan-Insufficient Responder…”
Get full text

Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S. Food and Drug Administration (FDA) adverse event reporting system (FAERS) dat... by Wen-Hui Liu, Hui-Min Hu, Chen Li, Qing Shi, Chun-Hua Liu, An-Xiang Liu, Yi-Fan Li, Yi Zhang, Peng Mao, Bi-Fa Fan

Subjects: “…Triptan medications…”
Get full text